Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease

Detalles Bibliográficos
Autores principales: Zou, Honghong, Zhou, Baoqin, Xu, Gaosi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844178/
https://www.ncbi.nlm.nih.gov/pubmed/29523130
http://dx.doi.org/10.1186/s12933-018-0676-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844178/
https://www.ncbi.nlm.nih.gov/pubmed/29523130
http://dx.doi.org/10.1186/s12933-018-0676-1

Ejemplares similares